List of insiders holdings for FIVE PRIME THERAPEUTICS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
2021-03-08 16:58:17 | 6,262,085 0 |
6,262,085 | Form 3 |
2 | ADAGE CAPITAL PARTNERS GP LLC Adage Capital Partners L.P. Adage Capital Advisors L.L.C. Atchinson Robert Gross Phillip 10% Owner |
2018-02-13 16:06:29 | 1,300,000 0 |
1,300,000 | Form 13G |
3 | Williams Lewis T Director |
2019-09-04 13:20:35 | 455,336 0 |
455,336 | Form 4 |
4 | Knickerbocker Aron Marc President & CEO |
2019-09-04 13:18:46 | 42,057 200,299 |
242,356 | Form 4 |
5 | Hambleton Julie EVP & Chief Medical Officer |
2015-11-13 17:04:38 | 137,201 1,764 |
138,965 | Form 4 |
6 | Wong Brian Russell SVP, Research |
2015-06-24 17:11:45 | 117,464 0 |
117,464 | Form 3 |
7 | Sikorski Robert Steven SVP and Chief Medical Officer |
2017-03-03 13:36:16 | 104,158 0 |
104,158 | Form 4 |
8 | Baker Kevin Paul SVP, Development Sciences |
2018-02-28 19:23:08 | 98,184 0 |
98,184 | Form 4 |
9 | Belsky Marc Senior Vice President and CFO |
2018-02-28 19:24:47 | 34,314 44,158 |
78,472 | Form 4 |
10 | Borges Luis SVP, Research |
2017-03-03 13:29:09 | 64,888 0 |
64,888 | Form 4 |
11 | Irving Bryan EVP, Chief Scientific Officer |
2019-05-16 18:29:24 | 30,533 0 |
30,533 | Form 4 |
12 | Douglas R Lee Director |
2016-10-13 13:02:19 | 1,220 15,642 |
16,862 | Form 4 |
13 | Kavanaugh William Michael SVP & Chief Scientific Officer |
2014-08-26 17:15:48 | 15,000 0 |
15,000 | Form 4 |
14 | ATWOOD BRIAN G Director |
2015-06-16 17:16:31 | 12,500 0 |
12,500 | Form 4 |
15 | MCDADE MARK Director |
2018-05-14 20:18:30 | 10,000 0 |
10,000 | Form 4 |
16 | Gujrathi Sheila Director |
2018-05-14 18:47:39 | 10,000 0 |
10,000 | Form 4 |
17 | Cohen Fred E Director |
2017-05-12 16:20:32 | 10,000 0 |
10,000 | Form 4 |
18 | Sarena Francis Willard Chief Strategy Officer |
2021-04-19 20:04:26 | 0 0 |
0 | Form 4 |
19 | Smith David V Executive Vice President & CFO |
2021-04-19 19:57:02 | 0 0 |
0 | Form 4 |
20 | Collins Helen Louise EVP and Chief Medical Officer |
2021-04-19 19:53:58 | 0 0 |
0 | Form 4 |
21 | White David See Remarks |
2021-04-19 19:49:04 | 0 0 |
0 | Form 4 |
22 | RINGO WILLIAM R Director |
2021-04-19 19:46:08 | 0 0 |
0 | Form 4 |
23 | BERGER FRANKLIN M Director |
2021-04-19 19:42:33 | 0 0 |
0 | Form 4 |
24 | Dhingra Kapil Director |
2021-04-19 19:39:43 | 0 0 |
0 | Form 4 |
25 | Jensen Peder Director |
2021-04-19 19:35:28 | 0 0 |
0 | Form 4 |
26 | Nicholson Garry A Director |
2021-04-19 19:32:22 | 0 0 |
0 | Form 4 |
27 | SCHAFER CAROL Director |
2021-04-19 19:28:40 | 0 0 |
0 | Form 4 |
28 | Lyons-Williams Lori Director |
2021-04-19 19:25:16 | 0 0 |
0 | Form 4 |
29 | Civik Thomas President and CEO |
2021-04-19 19:21:50 | 0 0 |
0 | Form 4 |
30 | PFIZER INC 10% Owner |
2016-02-11 17:27:13 | 0 0 |
0 | Form 13G |
31 | Rubinstein Linda M Interim CFO |
2018-04-23 13:29:46 | 0 0 |
0 | Form 3 |